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Deubiquitinases are proteaseswith awide functional diversity
that profoundly impact multiple biological processes. Among
them, the ubiquitin-specific protease 36 (USP36) has been
implicated in the regulation of nucleolar activity. However, its
functional relevance in vivo has not yet been fully described.
Here, we report the generation of an Usp36-deficient mouse
model to examine the function of this enzyme. We show that
Usp36 depletion is lethal in preimplantation mouse embryos,
where it blocks the transition from morula to blastocyst during
embryonic development. USP36 reduces the ubiquitination lev-
els and increases the stability of the DEAH-box RNA helicase
DHX33, which is critically involved in ribosomal RNA synthesis
and mRNA translation. In agreement with this finding, O-pro-
pargyl-puromycin incorporation experiments, Northern blot,
and electron microscopy analyses demonstrated the role of
USP36 in ribosomal RNA and protein synthesis. Finally, we
show that USP36 down-regulation alters cell proliferation in
human cancer cells by inducing both apoptosis and cell cycle
arrest, and that reducing DHX33 levels through short hairpin
RNA interference has the same effect. Collectively, these results
support that Usp36 is essential for cell and organism viability
because of its role in ribosomal RNA processing and protein
synthesis, which is mediated, at least in part, by regulating
DHX33 stability.
Deubiquitinases, or DUBs,3 are a large group of proteases
with the ability to hydrolyze the isopeptide bond that link ubiq-
uitin chains to target proteins (1–4). There are six families of
DUBs grouped according to sequence and structural similari-
ties: ubiquitin-specific proteases (USPs), ubiquitin carboxyl-
terminal hydrolases, ovarian-tumor proteases, Machado-Jo-
seph disease protein domain proteases (MJDs), JAMM/MPN
domain-associatedmetallopeptidases (JAMMs), andmonocyte
chemotactic protein-induced protein family (5). Over the last
years, DUBs have attracted especial interest due to their wide
functional diversity and profound impact on the regulation of
multiple biological processes (2, 6, 7). The cysteine proteases of
the USP family represent the largest group of DUBs, with more
than 50 members in humans (8–10). Among them, USP36 has
been related to nucleolar activity regulation, through the deu-
biquitination of nucleophosmin/B23 and fibrillarin (11, 12).
Additionally, USP36 activity has also been implicated in
autophagy activation (13), as well as in oxidative stress regula-
tion by the stabilization ofmitochondrial superoxide dismutase
SOD2 (14). Interestingly, the Drosophila gene scrawny (scny),
which encodes an USP family protein homologous to human
USP36, has been described to inhibit H2B ubiquitination,
repressing the premature expression in stem cells of key differ-
entiation genes (15). The role of USP36 in the stabilization of
the oncogene c-Myc has also been reported (16). Finally, it has
been proposed that USP36 is critical for ribosome biogenesis
through the regulation of RNA polymerase I stability (17, 18).
Over the last years, several studies have shown that RNA
helicases comprise the largest family of enzymes that regulate
RNA metabolic processes, such as pre-mRNA splicing, RNA
editing, mRNA translation, and ribosome biogenesis (19). In
fact, it has been widely described that most RNA helicases con-
tribute to several steps of RNA metabolism, coordinating and
orchestrating gene expression patterns. The human genome
encodes 15 DEAH-box RNA helicases, which are RNA-binding
proteins with the ability to modify RNA structure through the
hydrolysis of ATP. One of these family members, DHX33, has
been implicated in nucleolar organization, ribosome biogene-
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sis, and protein synthesis. Thus, DHX33 promotes mRNA
translation initiation by regulating elongation-competent 80S
ribosome assembly (20) and modulates RNA polymerase I-di-
rected transcriptional activity through its interaction with the
DNA chromatin-modulating protein UBF (21).
In this work, the generation and characterization of mutant
mice deficient in Usp36 revealed that this DUB is an essential
enzyme for embryonic development. Additionally, this study
provides evidence that Usp36 regulates ribosomal RNA and
protein synthesis, and proposes a regulatory function for this
protease on the ubiquitination status and stability of Dhx33.
Altogether, these data identify USP36 as a deubiquitinating
enzyme whose function in rRNA processing and mRNA trans-
lation is critical for cell and organism viability.
Results
Usp36 deletion leads to embryonic lethality inmice
To study the biological function of the deubiquitinase
USP36, the Usp36 gene was disrupted in mice by homologous
recombination using a gene trap strategy (Fig. 1A). Heterozy-
gosity for themutationwas confirmedby Southern blot analysis
(Fig. 1B). Usp36 heterozygous mice were fertile and healthy
with no obvious abnormalities.However, when thesemicewere
intercrossed, no homozygous pups were detected at weaning
(Fig. 1C), suggesting that the complete absence of Usp36 causes
embryonic lethality. To further analyze how Usp36 deficiency
affects embryogenesis, embryos were collected at different
stages of development, from 2.5 to 14.5 days postcoitum (dpc).
As shown in Fig. 1C, homozygous mice were detected only at
the morula stage. To characterize the role played by Usp36
during the critical transition from morula to blastocyst,
embryos at 2.5 dpc were extracted and cultured in vitro. The
next day, some of themhad developed into blastocysts, whereas
other remained at the morula stage. A high proportion of these
morulae carried the homozygous mutation (Fig. 1D), whereas,
by contrast, all the blastocysts were wildtype or heterozygous
for Usp36.
To elucidate the mechanism by whichUsp36/ blastocysts
are unviable, TUNEL analysis was performed in these embryos.
Only 1 of 4 wildtype and 2 of 5 heterozygous morulae were
positive for TUNEL staining, whereas 4 of 4 Usp36-deficient
arrested morulae showed apoptotic markers, suggesting that
Usp36 deficiency activates apoptotic pathways that could
impede the transition from morula to blastocyst. Taken
together, these results demonstrate that Usp36 is essential for
embryo development and that its deficiency induces an apopto-
tic response at the morula stage that leads to preimplantation
lethality.
USP36 regulates DHX33 ubiquitination levels
To investigate the biochemical function ofUSP36, character-
ization of the proteomic profile of wildtype and Usp36-defi-
cient cells was undertaken. With this purpose, quantitative
mass spectrometry analysis using a tandem mass tag (TMT)
technique was performed with protein extracts from wildtype
and Usp36-heterozygous MEFs by triplicate. This proteomic
Figure 1. Usp36 depletion leads to preimplantation lethality. A, schematic representation of the gene trap strategy used for the generation of the
Usp36-deficient mouse model. B, Southern blot analysis performed on wildtype and Usp36-heterozygous mice. C, distribution of genotyped offspring and
embryos from Usp36/ intercrosses. Usp36/ embryos were not found beyond the morula stage. D, representative images of embryos obtained from
heterozygous intercrosses of Usp36/ mice obtained at 2.5 dpc (morulae) and cultured in vitro for 24 h (blastocysts, 3.5 dpc). E, TUNEL staining of 3.5 dpc
embryos revealed apoptosis in Usp36-depleted morulae.
USP36 loss destabilizes DHX33 and causes embryonic lethality
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approach allowed us to quantify over 7,200 proteins, revealing
changes in 251 proteins (Fig. 2A and Table S1). This analysis
showed that Usp36 protein levels in Usp36/ MEFs were
about 70% of those in Usp36/ fibroblasts (Fig. 2B and Table
S1). Similarly, the levels of Dhx33, a pivotal DEAH-box RNA
helicase involved in RNA polymerase I-mediated transcription
(21), were also reduced in Usp36/ MEFs to 70% of control
samples (Fig. 2C and Table S1). Dhx33 down-regulation in
MEFs was validated byWestern blot (Fig. 3A). Next,Usp36/
andUsp36/MEFswere treatedwith 1Mbortezomib during
18 h. As shown in Fig. 3A, proteasome inhibition induced the
accumulation of Dhx33 inUsp36/MEFs, to the same extent
as in wildtype MEFs, supporting that Dhx33 is regulated by the
ubiquitin-proteasome system. To investigate if USP36 and
DHX33 proteins interact each other, the human USP36 cDNA
was cloned fused to the C-terminal of GFP and overexpressed
into HEK-293T cells, together with pLVX–FLAG–DHX33.
Co-immunoprecipitation assays confirmed that ectopically
expressed GFP–USP36 could be detected in FLAG-tagged
DHX33 immunoprecipitates (Fig. 3B). In agreement with these
results, colocalization of USP36 and DHX33 was observed
through immunofluorescence analysis in HeLa cells trans-
fected with pLVX–FLAG–DHX33 and GFP–USP36 (Fig. 3C).
Furthermore, a Duolink In Situ Proximity Ligation Assay
(P-LISA) (22) showed that GFP-USP36 directly interacted with
FLAG-tagged DHX33 protein (Fig. 3D), supporting the inter-
action between both proteins. These findings are consistent
with the results from reported global proteomic studies (23, 24)
(Fig. S1) and a yeast two-hybrid assay (25), which confirms the
interaction between USP36 and DHX33.
To investigate whether USP36 regulates DHX33 levels
through deubiquitination, HEK-293T cells were transfected
with HA–ubiquitin and pLVX–FLAG–DHX33, with or with-
out USP36 overexpression. After treatment with bortezomib,
DHX33 was immunoprecipitated and its ubiquitination status
was analyzed using both anti-HA and anti-DHX33 antibodies.
As shown in Fig. 3E, USP36 overexpression reduced DHX33
ubiquitination and, accordingly, led to increased levels of
ectopically expressed DHX33. On the contrary, HEK-293T
transfected with anUSP36-specific shRNA showed an increase
in DHX33 ubiquitination levels (Fig. 3F). Altogether, these
results support that USP36 stabilizes DHX33 through the reg-
ulation of its ubiquitination status.
Usp36 deficiency impairs mRNA translation and rRNA
synthesis
The essentiality of Usp36 at an early stage of development
demonstrates its involvement in critical biological functions.
Among the molecular changes occurring at the transition from
morula to blastocyst, rDNA transcription and nucleoli matura-
tion have been reported to occur beyond the morula stage. In
this regard, DHX33 has a pivotal role as a promoter of mRNA
translation initiation (20). These facts suggested that USP36
deubiquitinase activity could have a role in protein synthesis, at
least in part, through the stabilization ofDHX33. To investigate
in vivo the role of Usp36 in this physiological process, morulae
at 2.5 dpc from intercrosses betweenUsp36-heterozygousmice
were extracted. At 3.5 dpc, embryos were treated with O-pro-
pargyl-puromycin (OP-Puro), an alkyne analog of puromycin
that forms covalent conjugates with nascent polypeptide chains
Figure 2. Dhx33 protein levels are reduced inUsp36-heterozygousMEFs. A, volcano plot showing the results obtained from protein extracts of Usp36/
and Usp36/MEFs that were analyzed by mass spectrometry using TMT technique. Data are represented as the ratio Usp36/ versus Usp36/, which was
calculated as the mean of the normalized signal obtained in Usp36/MEFs divided by the mean of the normalized signal obtained in Usp36/MEFs (n 3
biological replicates). B and C, Usp36 and Dhx33 protein levels from wildtype and Usp36-heterozygous MEFs, assessed by mass spectrometry, two-tailed
Student’s t test (**, p 0.01).
USP36 loss destabilizes DHX33 and causes embryonic lethality
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and can be visualized by copper(I)-catalyzed azide-alkyne
cycloaddition (26). As it is shown in Fig. 4A, deficiency ofUsp36
at themorula stage decreasedOP-Puro incorporation, suggest-
ing an impairment of mRNA translation.
Because DHX33 has also been described as a mediator or
rRNA synthesis (21), the role ofUSP36 in this phenomenonwas
next analyzed. With this purpose, 45S pre-rRNA levels of
USP36-depleted and control HCT116 colorectal cancer cells
were quantified by Northern blot analysis, finding that down-
regulation of USP36 significantly decreased 45S pre-rRNA
accumulation (Fig. 4, B and C). Moreover, silencing of USP36
also caused more alterations in pre-rRNA processing, such as
diminished 21S levels (Fig. 4, B and D), and consequently
increased the 28S/18S ratio (Fig. 4E). Because these results sup-
port a direct role of USP36 in the regulation of rRNA pro-
cessing, the hypothetical impact of Usp36 down-regulation on
thenucleolar structurewas investigatedbyanalyzingMEFspro-
cessed for electron microscopy. Interestingly,Usp36-heterozy-
gous MEFs showed nucleoli significantly larger than wildtype
MEFs (Fig. 5A). Although Usp36-heterozygous MEFs also
exhibited an increase in nucleus size (Fig. 5B), the ratio of
nucleolar to nuclear area was consistently higher when com-
pared with that of wildtype cells (Fig. 5, C andD). Finally, the
effect of USP36 down-regulation was examined through the
meta-analysis of the data derived from a genomewide shRNA
screen in 216 cancer cell lines from multiple tumor types
(27), finding that the antiproliferative effects of silencing
USP36 correlated positively with the antiproliferative effects
of silencing genes involved in translation and ribosome bio-
genesis (Fig. 5E).
Figure 3. USP36 regulates the ubiquitination levels of DHX33. A,Western blot analysis and densitometry quantification of Dhx33 levels in Usp36/ and
Usp36/ MEFs, before and after treatment with bortezomib, two-tailed Student’s t test (*, p  0.05). The densitometry quantification of each band was
normalized to the wildtype signal from the same blot to compare the data. B, FLAG- and GFP-specific Western blot analyses of FLAG immunoprecipitates
(IP:Flag) from HEK-293T cells transiently cotransfected with FLAG-tagged DHX33 plus either GFP-USP36 or GFP. C, colocalization of USP36 (green) and DHX33
(red) was analyzed through immunofluorescence analysis. Scale bar 20m.D, representative fluorescence images showing Duolink fluorescence as USP36
and DHX33 interaction (red signal), USP36 (GFP), and merged with DAPI. Scale bar 20 m. E, ubiquitination levels analyzed by Western blot (anti-HA and
anti-DHX33) of FLAG immunoprecipitates (IP:Flag) from HEK-293T cells transiently cotransfected with FLAG-tagged DHX33 and HA-ubiquitin plus either
GFP-USP36 or GFP expression vectors and treated with bortezomib. F, DHX33 protein levels and ubiquitination status analyzed byWestern blot (anti-HA and
anti-DHX33) of FLAG immunoprecipitates (IP:Flag) from HEK-293T cells transiently cotransfected with FLAG-tagged DHX33 and HA-ubiquitin plus either
pLKO.1 or USP36-specific shRNA vectors and treated with bortezomib.WCE, whole cell extracts.
USP36 loss destabilizes DHX33 and causes embryonic lethality
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Figure 5.USP36 down-regulation alters nucleolar structure. A and B, nucleolar (A) and nuclear (B) areas of Usp36/ and Usp36/MEFs. C, nucleolar area
normalized to nuclear area of Usp36/ and Usp36/ MEFs. D, representative images of MEFs processed for electron microscopy. E, GSEA analysis from a
genome-wide screenwith 216 cancer cell lines frommultiple tumor types (Broad Institute Project Achilles) showed that the antiproliferative effects of silencing
USP36 correlatedpositivelywithgene sets containinggenes involved in translationand ribosomebiogenesis. Selectedenrichedpathwayshada relaxedFDR
0.001 and p 0.001. Data are represented asmean S.E. and statistical significancewas assessed by using a non-parametric Mann-Whitney-Wilcoxon test (*,
p 0.05; ***, p 0.001).
Figure 4. USP36 depletion impairs protein and rRNA synthesis. A, representative images of 3.5 dpc embryos incubated with OP-Puro and visualized by
fluorescencemicroscopy after conjugationwith Alexa Fluor 488. The bar graph represents the quantification ofmean fluorescence obtained from40 embryos
at 3.5dpc. Fluorescencebaseline20.Data are representedasmeanS.E. and statistical significancewas assessedbyusinganon-parametricMann-Whitney-
Wilcoxon test (*, p 0.05). B, representative image of Northern blot analysis of RNA fromHCT116 cells transducedwith control (pLKO.1) or twoUSP36-specific
shRNAs (shUSP36.446 and shUSP36.447) and densitometry quantification of six technical replicates. The densitometry quantification of each band was
normalized to pLKO.1 signal from the same blot to compare the data. C and D, Northern blot analysis showed that down-regulation of USP36 decreased the
levels of 45S pre-rRNA (C) and 21S pre-rRNA (D), two-tailed Student’s t test (*, p  0.05; **, p  0.01). E, bioanalyzer experiments demonstrate that down-
regulation of USP36 increased the 28S/18S ratio, two-tailed Student’s t test (**, p 0.01).
USP36 loss destabilizes DHX33 and causes embryonic lethality
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Collectively, these results strongly support that USP36, sim-
ilarly to DHX33, is essential for the regulation of rRNA synthe-
sis andmRNA translation processes, whose optimal function is
required during embryonic development. In this sense, any dys-
functional mutation within Usp36 could lead to a devastating
effect, as demonstrated by the finding of preimplantation
lethality in Usp36-deficient mice.
USP36 depletion induces p53-independent apoptosis and
p53-dependent cell cycle arrest
To investigate the mechanistic intricacies underlying the
lethality caused by Usp36 depletion, HCT116 colorectal cancer
cellswere chosen as an experimentalmodel. As a first approach,
the proliferation rate of humanHCT116 colorectal cancer cells
transduced with either control or USP36-specific shRNAs was
analyzed. As shown in Fig. 6A, USP36 depletion with three
independent shRNAs, either separately or in combination,
decreased the proliferation rate of HCT116 cells. To demon-
strate the absence of noticeable off-target effects, a lentiviral
vector encoding a shRNA-resistant USP36 cDNA was trans-
duced into HCT116 cells. USP36 protein levels were analyzed
by Western blot (Fig. 6B). As shown in Fig. 6C, ectopic expres-
sion of this cDNAabrogated the effects of the shRNA-mediated
USP36 silencing in this cell line, corroborating the specificity
of our approach. Moreover, down-regulation of USP36 in
HCT116 cells reduced their ability to grow in soft agar (Fig. 6D).
Accordingly, USP36 depletion with three independent shRNAs
induced apoptosis, as evidenced by an increase in the percent-
age of Annexin V-positive cells (Fig. 6E). In agreement with
these results, Western blot analysis of PARP cleavage also con-
firmed apoptosis induction uponUSP36 down-regulation (Fig.
6F), corroborating the results obtained from TUNEL analysis
performed in Usp36 / morulae. To investigate whether
USP36 depletion alters cell cycle progression, the cell cycle pro-
file of wildtype and USP36-silenced cells was analyzed by flow
cytometry. Interestingly, USP36 down-regulation induced an
increased accumulation of cells in the G1 phase compared with
controls, suggesting a G1 cell cycle arrest (Fig. 6G). Altogether,
these results indicate that USP36 deficiency alters cell prolifer-
ation, inducing both apoptosis and cell cycle arrest.
To determine whether p53 plays a role in the apoptotic
response induced by USP36 silencing, USP36 was next down-
regulated in p53-deficient HCT116 cells. Remarkably, p53 defi-
ciency did not rescue the cell lethality caused by USP36 down-
Figure 6. USP36 silencing abrogates HCT116 proliferation. A, MTT proliferation assay of HCT116 cell transduced with control (pLKO.1) or three USP36-
specific shRNAs (shUSP36.445, shUSP36.446, and shUSP36.447) either separately or in combination (all shUSP36). B, Western blot analysis and densitometry
quantification of USP36 expression in HCT116 cells transduced with USP36-specific shRNA (shUSP36) and/or an shRNA-resistant USP36 cDNA (pCDH-USP36).
C, USP36 shRNA effects on HCT116 proliferation were rescued by the overexpression of a USP36 shRNA-resistant cDNA. D, soft agar colony formation assay
showing anchorage-independent growth of control and USP36-depleted HCT116 cells. E, Annexin V-FITC positive cells were analyzed by flow cytometry in
USP36-silenced and control cells. The percentage of Annexin V-FITC positive cells of each condition was normalized with that of control cells (pLKO.1). F,
Western blot analysis and densitometry quantification of HCT116 cells transduced with empty vector and USP36-specific shRNAs showing USP36 down-
regulation and apoptosis induction (PARP cleavage). G, flow cytometry-based cell cycle analysis showing an increase in G1 population upon USP36 down-
regulation, two-tailed Student’s t test (*, p 0.05; **, p 0.01; ***, p 0.001). Data from MTT proliferation, soft agar colony formation, and Annexin V-FITC
assays are presented asmean S.E. and statistical significancewas assessed by using a non-parametricMann-Whitney-Wilcoxon test (*, p 0.05; **, p 0.01).
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regulation (Fig. 7A). Furthermore, USP36-depleted cells
underwent some degree of apoptosis even in the absence of p53
(Fig. 7, B and C), indicating that USP36 down-regulation
induces a p53-independent apoptotic response. By contrast, a
significant increase in G1 population cells was not observed
afterUSP36 silencing, although the accumulation of cells in G2
phase of the cycle was noteworthy (Fig. 7D). Altogether, these
results suggest that USP36 depletion induces both p53-depen-
dent cell cycle arrest and p53-independent apoptosis. Next, we
decided to investigate the possible relevance of these mecha-
nisms in the embryonic lethality caused by Usp36 deficiency.
With this purpose, p53/ mice were crossed with Usp36/
mice, which were then inbred to obtain Usp36/ p53/
mice. Finally, these mice were intercrossed and the resulting
offspring genotyped and analyzed. As shown in Fig. 7E, no
Usp36/ p53/micewere detected atweaning.Next, 2.5 dpc
embryos were collected and cultured in vitro for 2 days to
obtain blastocysts. However, no Usp36/ p53/ blastocysts
were found. By contrast, we obtained some Usp36/ p53/
arrested morulae (Fig. 7E). Therefore, these results demon-
strate thatUsp36/ embryos exhibit preimplantation lethality
at the morula stage in a p53-independent manner.
Finally, to further evaluate if DHX33 down-regulation mim-
ics the biological effect caused by USP36 depletion, an empty
vector (pLKO.1) and two independent DHX33-specific shR-
NAs (shDHX33.61 and shDHX33.62) were transduced into
HCT116 cells. As observed upon USP36 targeting, silencing of
DHX33 in HCT116 cells significantly reduced their prolifera-
tion rate (Fig. 8A). Western blot analyses were performed to
analyze DHX33 protein levels (Fig. 8B). Furthermore, cells
transduced with DHX33-specific shRNAs showed an increase
in apoptosis, as evidenced by analyzing both PARP cleavage
(Fig. 8C) and the percentage of Annexin V-FITC positive cells
(Fig. 8D). Altogether, these results corroborate that DHX33
down-regulation phenocopies USP36 silencing in human can-
cer cells, and support our hypothesis that USP36 is essential for
cell viability due to its critical role in rRNA processing and
protein synthesis by regulating the ubiquitination levels of
DHX33.
Discussion
In this work, we have generated an Usp36-deficient mouse
model that shows a lethal phenotype during the preimplanta-
tion stage, demonstrating the essentiality of this deubiquitinase
for embryonic development. Moreover, we have evaluated the
functional role of USP36 by analyzing the proteomic profile of
wildtype and heterozygous mice for this deubiquitinase. Our
studies have shown that USP36 directly interacts with DHX33,
a DEAH-box RNA helicase involved in RNA polymerase I-me-
diated transcription and mRNA translation initiation (20, 21).
Furthermore, we have described for the first time the regulatory
role of USP36 on the ubiquitination levels and stability of
DHX33.
So far, many nucleolar proteins associated with RNA pro-
cessing have been described as essential for proliferation and
survival of human cells (28, 29). Furthermore, several mouse
Figure7.USP36down-regulation inducesp53-independentapoptosis andp53-dependent cell cyclearrest.A,MTTproliferationassayofHCT116p53/
cells stably transducedwith control andUSP36-specific shRNAs. Absorbance of each day is normalizedwith respect to absorbance of day 0. Data are presented
as mean S.E. and statistical significance was assessed by using a non-parametric Mann-Whitney-Wilcoxon test (**, p 0.01). B, Western blot analysis and
densitometry quantification of PARP cleavage as an indicator of apoptosis in protein extracts of HCT116 p53/ and p53/ cells transducedwith control and
USP36-specific shRNAs. C, Annexin V-FITC positive cells levels of USP36-silenced and control cells. The percentage of Annexin V-FITC positive cells of each
condition was normalized with respect to that of control cells (pLKO.1). D, flow cytometry-based cell cycle analysis of wildtype and USP36-silenced HCT116
p53/ cells, two-tailed Student’s t test (*, p 0.05; **, p 0.01). E, distribution of genotyped offspring and embryos from Usp36/ p53/ intercrosses and
representative images of embryos from intercrosses ofUsp36/ p53/mice obtained at 2.5 dpc (morulae) and cultured in vitro for 48 h (blastocysts, 4.5 dpc).
USP36 loss destabilizes DHX33 and causes embryonic lethality
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models deficient for ribosome biogenesis regulators also show
embryonic lethality at the preimplantation stage. Thus, Pesca-
dillo-deficient mouse embryos arrest at the morula stage of
development (30). Similarly, mice carrying a truncated muta-
tion in the gene encoding polypeptide B of RNA polymerase I
display nucleolus disruption and apoptotic cell death at the
morula stage (31). Furthermore, fibrillarin-deficient mouse
embryos also die beyond themorula stage (32) and Surf6 knock-
downbyRNAi results in development arrest at themorula stage
(33). Finally, UBF and nucleostemin are also essential for
embryo development beyond morula (34, 35). The results
derived from our study have demonstrated in vivo that Usp36 is
a nucleolar protein related to ribosome biogenesis and RNA
processing regulation. Thus, OP-Puro treatment has demon-
strated that Usp36-deficient morulae exhibit impaired protein
synthesis, highlighting the importance of Usp36 in this cellular
process. Moreover, Northern blot analysis has shown that
USP36 deficiency induce aberrations in rRNA synthesis.
According to USP36 nucleolar activity, Usp36-heterozygous
MEFs exhibit alterations in their nucleolar structure, a phe-
nomenon that has been tightly correlated with ribosome bio-
genesis aberrations (36). In agreement with these results, meta-
analysis of a genome-scale shRNA screen of 216 cancer cell
lines of multiple histological origins has revealed that the anti-
proliferative effects of silencing USP36 and genes involved in
translation and ribosome biogenesis positively correlate, sup-
porting the direct role of this deubiquitinating enzyme in both
physiological processes. Altogether, these results strongly sup-
port the critical role of USP36 in rDNA transcription and
mRNA translation, at least in part, by regulating the stability of
DHX33. However, further studies on other putative USP36
substrates will be required to completely understand its func-
tional role in these biological processes.
It is widely accepted that inappropriate ribosome biogenesis,
perturbedrRNAprocessing,andribosomeassemblyinduceapo-
ptosis and block cell proliferation (36, 37). Accordingly, the
results obtained in TUNEL experiments have revealed that
Usp36 deficiency induces apoptosis at the preimplantation
stage of development. Furthermore,we have demonstrated that
USP36 down-regulation with specific shRNAs reduces the pro-
liferation and the anchorage-independent growth of human
cancer cells, through both p53-dependent and -independent
mechanisms. Thus, even in the absence of p53,USP36 ablation
leads to cell death, both in human colorectal cancer cells and in
preimplantation mouse embryos. Additionally, we have dem-
onstrated that reducing DHX33 protein levels by an USP36-
independent mechanism also abrogates the proliferation of
HCT116 cells and increases their apoptotic rate, supporting our
hypothesis that the USP36 role in regulating DHX33 stability is
critically required for cell viability.
In summary, the generation of Usp36-deficient mice has
allowed us to identify USP36 as an essential gene for cell and
organism viability.We describe for the first time the regulatory
role of USP36 on the ubiquitination levels and stability of
DEAH-box RNA helicase DHX33, which constitutes a new
mechanism of USP36 functional implication in rRNA pro-
cessing and protein synthesis.
Experimental procedures
Generation of Usp36/mice and genotyping
Usp36-mutant embryonic stem cells were purchased from
EUKOMP (EUCE00141e03, from the 129P2/OlaHsd mouse
Figure 8. shRNA-mediated down-regulation of DHX33 phenocopies USP36 silencing. A, MTT proliferation assay of the HCT116 cells transduced with
control (pLKO.1) or twoDHX33-specific shRNAs (shDHX33.61 and shDHX33.62). B,Western blot analysis and densitometry quantification of DHX33 expression
in HCT116 cells used in A. C, Western blot analysis of PARP cleavage as an indicator of apoptosis in protein extracts of HCT116 cells transduced with control
(pLKO.1) or DHX33-specific shRNAs (shDHX33.61 and shDHX33.62). D, flow cytometry assay showing the percentage of Annexin V-FITC positive cells as an
indicator of early apoptosis.
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strain). Two different clones of targeted embryonic stem cells
weremicroinjected intoC57BL/6mouse blastocysts to produce
chimeric mice that were then subsequently crossed with
C57BL/6 mice to generate Usp36-heterozygous mice. Usp36-
knockout first allele was identified by Southern blotting and
PCR. For Southern blot experiments, the recombinant allele
(3,640 bp) was detected by a specific probe in BclI-digested
genomic DNA. For PCR genotyping, genomic DNA from tail
samples was used under the following conditions: denaturation
at 94 °C for 30 s, annealing at 60 °C for 30 s, and extension at
72 °C for 30 s, 30 cycles. The following primers were used for
genotyping: wildtype-specific forward 5-ccaggtctctcaaggac-
tagga-3, mutation-specific forward 5-gaatgaaagaccccacctg-
tag-3, and common reverse 5-aggatgccaaagagcatgtagt-3.
p53-deficient mice were kindly provided by Dr. M. Serrano.
Cell culture
Cancer cell lines HEK-293T, HeLa, and HCT116 were
purchased from the American Type Culture Collection.
Cells were routinely maintained in Dulbecco’s modified
Eagle’s medium containing 10% fetal bovine serum, 100
units/ml of penicillin, and 100 g/ml of streptomycin (Life
Technologies). HCT116 p53/ cells were kindly provided
by Dr. B. Vogelstein. MEFs were extracted and cultured as
previously described (38).
Cell cycle analysis
HCT116 cells transduced with control andUSP36-specific
shRNAs were washed twice with PBS and permeabilized
with 1ml of 70% ethanol at20 °C added drop by drop. After
30 min on ice, cells were washed twice in PBS and resus-
pended in 1 ml of 20 g/ml of propidium iodide (PI), 200
g/ml of RNase in PBS for 15 min in the dark at room tem-
perature. Finally, the cell cycle was analyzed by flow cytom-
etry (10,000 events per sample, Cytomics FC500, Beckman
Coulter).
shRNA lentiviral infection
USP36-specific shRNAs, DHX33-specific shRNAs, and
empty vector (pLKO.1) (Open Biosystems, Thermo Scien-
tific) were packaged in HEK-293T cells using a vesicular
stomatitis virus glycoprotein-based package system. Viral
supernatant was collected at 24 h and added in a 1:3 dilution
to previously seeded HCT116 cells, supplemented with 5
mg/ml of Polybrene (Millipore). HCT116 stably transduced
cells were selected with puromycin at a final concentration
of 1 g/ml.
Cell-proliferation assay
To quantify cell proliferation, 5,000 cells per well were
seeded (n  6) into 96-well plates and a Cell Titer 96 NonRa-
dioactive cell proliferation kit was used following the manufa-
cturer’s instructions (Promega Corp.).
shRNA-resistant USP36 expression
Silent mutations were introduced into the shUSP36.447
target sequence of USP36 cDNA cloned in pCDH-puro,
using the Q5 Site-directed Mutagenesis Kit (New England
Biolabs) and the primers: 5-ggcttacagccgacatcttgccatcccaggt-
3 and 5-aagacgccatcgaagacagcagacaggcccgga-3. Lentiviral
particles were packaged as described above. HCT116 cells were
simultaneously transduced with the USP36-specific shRNAs
shUSP36.447 and the shRNA-resistant USP36 cDNA or the
empty vector and their proliferation was assessed without
prior antibiotic selection. It is noteworthy that HCT116 cells
were simultaneously transduced with two different plasmids
(USP36-specific shRNAs and a shRNA-resistant USP36 cDNA
clone), which shared the same antibiotic resistance, leading to a
smaller fraction of silenced cells. Therefore, the anti-prolifera-
tive effect of this experiment was smaller and observed later
when compared with that of Fig. 6A.
Soft agar colony formation
1,000 cells per well were seeded, maintained during 8 days
at 37 °C and 5% CO2 and anchorage-independent growth
was analyzed with CytoSelectTM 96-Well In Vitro Tumor
Sensitivity Assay kit (Cell Biolabs), following the manufactu-
rer’s instructions.
Northern blot
A total of 10 g of denatured RNA was separated by electro-
phoresis on 1.2% agarose gels and transferred to Hybond N
(Amersham Biosciences). Blots were prehybridized at 42 °C for
3 h in 50% formamide, 5 SSPE (1  150 mM NaCl, 10 mM
NaH2PO4, 1mMEDTA, pH7.4), 10Denhardt’s solution, 1.4%
SDS, and 100 g/ml of denatured herring sperm DNA. Then,
the blot was hybridizedwith a genomicDNAprobe synthetized
by PCR using the following primers: 5-gagaactcgggagggaga-
c-3 and 5-gaccctcgagacgcccta-3 for 24 h under the same con-
ditions. Blotswerewashed twicewith 2 SSC, 0.05%SDS for 20
min at room temperature. Finally, blots were washed three
times with 0.1 SSC, 0.1% SDS for 20min at 50 °C and exposed
to autoradiography.
Western blot analysis
Western blot analyses were performed as previously
described (39) using the following antibodies: anti-USP36
antibody (14783-1-AP, Proteintech), anti-PARP (9542, Cell
Signaling), anti-p53 (sc-126, Santa Cruz Biotechnology),
anti-DHX33 (NB100–2581, Novus Biologicals), anti-FLAG
(2368, Cell Signaling), anti--actin (AC-15, Sigma), anti--
tubulin (T6074, Sigma), and anti-HA (11867423001, Roche
Applied Science).
Annexin V analysis and PI staining
HCT116 cells transduced with either control, USP36-spe-
cific shRNAs or DHX33-specific shRNAs, were labeled with
Annexin V-FITC (Inmunostep) and PI for 10 min in the dark.
The percentage of positive Annexin V cells was analyzed by
Flow Cytometry (15,000 events per sample).
TUNEL andOP-Puro treatment
Embryos derived from Usp36-heterozygous mice inter-
crosses were flushed at day 2.5 dpc and cultured overnight. For
OP-Puro experiments, embryos at 3.5 dpc were incubated with
50 M OP-Puro for 1 h at 37 °C. Then, they were washed with
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PBS and fixed in 4%paraformaldehyde in PBS for 5min at room
temperature. They were subsequently washed with PBS and
permeabilized in 0.1% Triton X-100, 0.1% sodium citrate for 2
min. Embryos were washed with 2% BSA in PBS and the azide-
alkyne cycloaddition was performed using the Click-iT Cell
Reaction Buffer Kit (Life Technologies) and azide conjugated to
Alexa Fluor 488 (Life Technologies) at a 5 M final concentra-
tion. After 30 min of incubation at room temperature, morulae
were washed with 2% BSA in PBS and images were taken using
a Leica TCS-SP8X laser confocal microscope (HCX PL FLU-
OTAR L 20/0.40 DRY, zoom 2.70). For TUNEL staining,
embryos were fixed and permeabilized as for OP-Puro experi-
ments. Embryos were then washed with PBS and incubated
with terminal deoxynucleotidyltransferase and fluorescein-la-
beled dUTP for terminal deoxynucleotidyltransferase-medi-
ated dUTP-biotin nick end labeling (TUNEL) (In Situ Cell
Death Detection kit; Roche Applied Science) at 37 °C for 1 h.
Embryos were washedwith PBS before they were analyzedwith
a Leica DMI6000B inverted microscope and photographed
with a Leica DFC480 camera (Leica Image Manager software).
After analysis, embryos were individually transferred into PCR
tubes and processed for genotyping.
Electronmicroscopy
MEFs were collected and fixed in 3% glutaraldehyde in caco-
dylate buffer. Then, they were transferred into agar, and post-
fixed with 1% osmium tetroxide for 1 h. We then rinsed the
samples 3 times in Sorensen’s buffer and agar blockswere dehy-
drated in graded ethanol and infiltrated in 50%propylene oxide,
50% resin. After 1 h, samples were embedded in a resin-based
mold for polymerization overnight at 37 °C. Finally, ultra-thin
sections (85 nm) were taken from each experiment and ana-
lyzed on a Jeol (JEM-1011) transmission electronmicroscope at
60 kV.
Sample preparation formass spectrometry
Protein samples were prepared by triplicate from wildtype
and Usp36-heterozygous MEFs in 150-mm dishes. Cells were
washed twice with ice-cold PBS, scraped in PBS, spun down,
and lysed in SDS buffer (2% SDS, 150 mM NaCl, 50 mM HEPES
pH 8.0, with added complete protease inhibitors (Roche
Applied Science) and PhosSTOP phosphatase inhibitors
(Roche Applied Science). 25-Guage needles were used to
homogenize the cell pellet and lyse it. Cell debris was spun
down for 15 min at 13,000  g at 4 °C. Protein concentration
was determined using the BCA assay (Thermo Fisher Scien-
tific). To reduce and alkylate the disulfide bonds, 300 g of
lysate was incubated with 5 mM tris(2-carboxyethyl)phosphine
for 30 min and 14 mM iodoacetamide for 30 min at room tem-
perature in the dark. Proteins were precipitated using metha-
nol/chloroform precipitation and resuspended in 8 M urea
buffer (8 M urea, 50 mM HEPES, pH 8.0, 1 mM CaCl2). Protein
extracts were diluted to 4 M urea using 50 mM HEPES, pH 8.0,
and digested for 2 h at 37 °C with LysC (Wako) at a 1:250 LysC/
protein ratio. Then, diluted to 2 M urea, and incubated over-
night at 37 °Cwith LysC. The next day, urea was further diluted
to 1 M and trypsin (Promega) was added at a 1:50 trypsin/pro-
tein ratio for 6 h at 37 °C. The proteolytic peptides were then
acidifiedwith formic acid (FA) to a pHof2 and desalted using
Sep-PakC18 solid-phase extraction cartridges (Waters), follow-
ing the manufacturer’s protocol. Dried peptides were resus-
pended in 200mMHEPES, pH 8.0, the concentrationwas deter-
mined using the micro-BCA protein assay (Thermo Fisher
Scientific) and the isobaric labeling of the peptides was per-
formed using 6-plex TMT reagents (Thermo Fisher Scientific).
Thus, 100g of peptides at 1g/l were labeled with 0.2 mg of
each TMT reagent (previously dissolved in acetonitrile (ACN))
for 2 h at room temperature. Finally, the reactions were
quenched with 0.3% hydroxylamine (Sigma) at room tempera-
ture for 15 min. The resultant labeled peptides were combined
equally and ACN diluted to 3% with 3% FA (final pH should be
2). The peptides were desalted again with a Sep-Pak C18 col-
umn and dried down in the SpeedVac. The peptides were then
subjected to basic-pH reverse-phase HPLC fractionation as
described (40) and fractionated into 24 fractions. Half of them
were dried down in the SpeedVac, dissolved in 3% FA, 3%ACN,
desalted via StageTip, dried again in the SpeedVac, and resus-
pended in 10 l of 3% FA, 3% ACN just before mass spectrom-
etry analysis.
Mass spectrometry analysis
All spectra were acquired on an Orbitrap Fusion (Thermo
Fisher Scientific) coupled to a Proxeon EASY-nLC II LC pump
(Thermo Fisher Scientific) as described previously (40). Briefly,
peptides were separated on an in-house packed column with
	35 cm of GP-18 resin (1.8 m, 200 Å; Sepax) using a gradient
of 135 min from 6 to 26% ACN in 0.125% FA at a flow rate of
	350 nl/min. The scan sequence in the mass spectrometer
began with FTMS1 spectra (resolution of 120 k; mass range
400–1400 m/z; automatic gain control (AGC) target 2  105,
maximum injection time of 100ms) followed by the selection of
the 10 most intense ions for MS/MS with a dynamic exclusion
of 90 s. ITMS2 spectra were collected in the ion trap with a
maximum injection time of 150 ms with an AGC target of 4
103 and CID collision energy of 35%. FTMS3 spectra were col-
lected using themulti-notchmethod previously described (41).
Briefly, to create TMT reporter ions, a synchronous-precursor-
selection-MS3 scan was collected on the top 10 most intense
ions in the MS2 spectrum. Synchronous-precursor-selection-
MS3 precursors were fragmented by high energy collision-in-
duced dissociation and analyzed using the Orbitrap (NCE 
55%, AGC 5 104, maximum injection time 150 ms, and
resolution  15 K). The data analysis were performed with a
SEQUEST-based in-house software pipeline (42). In short,
mass spectra were searched against the mouse Uniprot data-
base (February 2014) and a reverse decoy database. Precursor
ion tolerancewas set at 20 ppm and product ion tolerance at 0.9
Da. Addition of a TMT tag (229.1629 Da) on lysine residues
and peptide N termini, and cysteine carbamidomethylation
(57.0215 Da) were added as static modifications, and methi-
onine oxidation (15.9949 Da) was set as a variable modifica-
tion. Peptide-spectrum matches were adjusted to a 1% false
discovery rate using a linear discriminant analysis (42), quanti-
fied by extracting the signal to noise ratio and proteins were
further collapsed to a final protein level false discovery rate of
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1% (40, 41). Statistical analysis was performed using two-tailed
Student’s t test.
Immunoprecipitation
HEK-293T cells were transfected with pLVX–FLAG–
DHX33 and pEGFP–USP36 or pEGFP empty vector and
immunoprecipitation was performed as previously described
(43). For ubiquitination experiments, HEK-293T cells were
transfected with HA–ubiquitin and pLVX–FLAG–DHX33,
together with pEGFP/pEGFP-USP36 or pLKO.1/USP36-spe-
cific shRNA plasmids, treated with 500 nM bortezomib during
16 h and lysed with RIPA buffer (100 mM Tris-HCl, pH 7.4,
150 mM NaCl, 10 mM EDTA, 1% sodium deoxycholate, 1%
Triton X-100, 0.1% SDS and protease and phosphatase
inhibitors). Then, protein extracts were precleared for 4 h at
4 °C with DynabeadsTM Protein G (Life Technologies),
released from beads and incubated in rotation with anti-
FLAG antibody overnight at 4 °C. Beads were next washed
three times with co-IP buffer and incubated in rotation with
antibody-conjugated protein extracts 4 h at room tempera-
ture. Immunoprecipitates and input samples were resolved
by SDS-PAGE and immunostained with anti-HA and anti-
DHX33 antibodies.
P-LISA and imunofluorescent staining
The interaction between USP36 and DHX33 was detected
using P-LISA (Sigma).HeLa cells were seeded on coverslips and
co-transfectedwith pEGFP–USP36 andpLVX–FLAG–DHX33
plasmids. After 24 h, coverslips were fixed with 4% paraformal-
dehyde for 10 min, permeabilized with 0.5% Triton X-100 for 5
min, and blocked with Duolink blocking buffer for 30 min at
37 °C in a humidity chamber. Incubation with anti-FLAG and
anti-USP36 antibodies was carried out overnight at 4 °C in a
humidity chamber. Incubation with secondary probes, ligation,
and amplification steps were all performed according to the
manufacturer’s instructions. For immunofluorescent staining,
HeLa cells transfected with pEGFP–USP36 and pLVX–FLAG–
DHX33 plasmids were fixed, permeabilized as indicated
above, and blocked with 15% goat serum for 1 h at room
temperature. Incubation with anti-FLAG and anti-GFP anti-
bodies was performed overnight at 4 °C in a humidity cham-
ber. Secondary antibody incubation was carried out 1 h at
room temperature. Then, cells were washed twice with PBS
for 5 min and coverslips were mounted with ProLongTM
Gold Antifade Mountant with DAPI (Invitrogen, Thermo
Fisher Scientific). Positive cells were visualized in an
Axioplan-2 fluorescence microscope (Zeiss) under a 100
oil immersion objective.
GSEA
Gene Set Enrichment Analysis (GSEA) was performed
as described (44) using GSEA release 2.06 and MSigDB
release 2.5 (http://www.broadinstitute.org/gsea/index.jsp).4
Selected enriched pathways had a relaxed FDR  0.001 and
p  0.005.
Author contributions—J. M. F. performed the experimental work,
data interpretation, and preparation of the manuscript. F. R. partic-
ipated in the generation of knockoutmice and in themanipulation of
embryos. D. C.-I., A. A., R. V.-B., N. V.-D., and J. I. M. S. performed
experimental work. M. A. P., J. A. P., and S. P. G. carried out pro-
teomic studies. J. M. P. F. and C. L.-O. supervised research and pro-
ject planning, data interpretation, and preparation of the manu-
script. All authors discussed the results and implications and
commented on the manuscript at all stages.
Acknowledgments—We thank Drs. G. Bretones, C. Bárcena, G.
Velasco, R. Valdés-Mas, V. Quesada, Y. Español, D. Rodríguez, A.
Salas and J. A. Vega, for helpful comments and assistance, and M.
Serrano, B. Vogelstein, and J. Weber for providing reagents. We also
thank the generous support by J. I. Cabrera. The Instituto Universita-
rio de Oncología is supported by Fundación Bancaria Caja de Ahor-
ros de Asturias.
References
1. Clague, M. J., Heride, C., and Urbé, S. (2015) The demographics of the
ubiquitin system. Trends Cell Biol. 25, 417–426 CrossRef Medline
2. Komander, D., Clague, M. J., and Urbé, S. (2009) Breaking the chains:
structure and function of the deubiquitinases.Nat. Rev. Mol. Cell Biol. 10,
550–563 CrossRef Medline
3. Ronau, J. A., Beckmann, J. F., and Hochstrasser, M. (2016) Substrate spec-
ificity of the ubiquitin and Ubl proteases. Cell Res. 26, 441–456 CrossRef
Medline
4. Ciechanover, A. (2015) The unravelling of the ubiquitin system.Nat. Rev.
Mol. Cell Biol. 16, 322–324 CrossRef Medline
5. Fraile, J. M., Quesada, V., Rodríguez, D., Freije, J. M., and López-Otin, C.
(2012) Deubiquitinases in cancer: new functions and therapeutic options.
Oncogene 31, 2373–2388 CrossRef Medline
6. Reyes-Turcu, F. E., Ventii, K. H., and Wilkinson, K. D. (2009) Regulation
and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu.
Rev. Biochem. 78, 363–397 CrossRef Medline
7. Clague, M. J., Barsukov, I., Coulson, J. M., Liu, H., Rigden, D. J., and Urbé,
S. (2013) Deubiquitylases from genes to organism. Physiol. Rev. 93,
1289–1315 CrossRef Medline
8. Quesada, V., Ordóñez, G. R., Sánchez, L. M., Puente, X. S., and López-
Otin, C. (2009) The Degradome database: mammalian proteases and dis-
eases of proteolysis.Nucleic Acids Res. 37,D239–D243 CrossRefMedline
9. Wang, Z., Zhang, H., Liu, J., Cheruiyot, A., Lee, J. H., Ordog, T., Lou, Z.,
You, Z., and Zhang, Z. (2016) USP51 deubiquitylates H2AK13,15ub and
regulates DNA damage response. Genes Dev. 30, 946–959 CrossRef
Medline
10. Ashton-Beaucage, D., Lemieux, C., Udell, C. M., Sahmi, M., Rochette, S.,
and Therrien, M. (2016) The deubiquitinase USP47 stabilizes MAPK by
counteracting the function of the N-end rule ligase POE/UBR4 in Dro-
sophila. PLos Biol. 14, e1002539 CrossRef Medline
11. Endo, A., Kitamura, N., and Komada, M. (2009) Nucleophosmin/B23 reg-
ulates ubiquitin dynamics in nucleoli by recruiting deubiquitylating en-
zyme USP36. J. Biol. Chem. 284, 27918–27923 CrossRef Medline
12. Endo, A., Matsumoto, M., Inada, T., Yamamoto, A., Nakayama, K. I., Ki-
tamura, N., and Komada, M. (2009) Nucleolar structure and function are
regulated by the deubiquitylating enzymeUSP36. J. Cell Sci. 122, 678–686
CrossRef Medline
13. Taillebourg, E., Gregoire, I., Viargues, P., Jacomin, A. C., Thevenon, D.,
Faure, M., and Fauvarque, M. O. (2012) The deubiquitinating enzyme
USP36 controls selective autophagy activation by ubiquitinated proteins.
Autophagy 8, 767–779 CrossRef Medline
14. Kim, M. S., Ramakrishna, S., Lim, K. H., Kim, J. H., and Baek, K. H. (2011)
Protein stability of mitochondrial superoxide dismutase SOD2 is regu-
lated by USP36. J. Cell Biochem. 112, 498–508 CrossRef Medline
4 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
USP36 loss destabilizes DHX33 and causes embryonic lethality
J. Biol. Chem. (2018) 293(6) 2183–2194 2193
 at U
N
IV
ERSID
A
D
 D
E O
V
IED
O
 on D
ecem
ber 10, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
15. Buszczak, M., Paterno, S., and Spradling, A. C. (2009) Drosophila stem
cells share a common requirement for the histone H2B ubiquitin protease
scrawny. Science 323, 248–251 CrossRef Medline
16. Sun, X. X., He, X., Yin, L., Komada, M., Sears, R. C., and Dai, M. S. (2015)
The nucleolar ubiquitin-specific protease USP36 deubiquitinates and sta-
bilizes c-Myc. Proc. Natl. Acad. Sci. U.S.A. 112, 3734–3739 Medline
17. Richardson, L. A., Reed, B. J., Charette, J. M., Freed, E. F., Fredrickson,
E. K., Locke, M. N., Baserga, S. J., and Gardner, R. G. (2012) A conserved
deubiquitinating enzymecontrols cell growthby regulatingRNApolymer-
ase I stability. Cell Rep 2, 372–385 CrossRef Medline
18. Peltonen, K., Colis, L., Liu, H., Trivedi, R., Moubarek,M. S., Moore, H.M.,
Bai, B., Rudek, M. A., Bieberich, C. J., and Laiho, M. (2014) A targeting
modality for destruction of RNA polymerase I that possesses anticancer
activity. Cancer Cell 25, 77–90 CrossRef Medline
19. Bourgeois, C. F., Mortreux, F., and Auboeuf, D. (2016) The multiple func-
tions of RNA helicases as drivers and regulators of gene expression. Nat.
Rev. Mol. Cell Biol. 17, 426–438 CrossRef Medline
20. Zhang, Y., You, J., Wang, X., and Weber, J. (2015) The DHX33 RNA
helicase promotes mRNA translation initiation. Mol. Cell Biol. 35,
2918–2931 CrossRef Medline
21. Zhang, Y., Forys, J. T., Miceli, A. P., Gwinn, A. S., and Weber, J. D. (2011)
Identification of DHX33 as a mediator of rRNA synthesis and cell growth.
Mol. Cell Biol. 31, 4676–4691 CrossRef Medline
22. Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius,
K. J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L. G., and
Landegren, U. (2006)Direct observation of individual endogenous protein
complexes in situ by proximity ligation. Nat. Methods 3, 995–1000
CrossRef Medline
23. Sowa,M. E., Bennett, E. J., Gygi, S. P., andHarper, J.W. (2009)Defining the
human deubiquitinating enzyme interaction landscape. Cell 138,
389–403 CrossRef Medline
24. Huttlin, E. L., Ting, L., Bruckner, R. J., Gebreab, F., Gygi, M. P., Szpyt, J.,
Tam, S., Zarraga, G., Colby, G., Baltier, K., Dong, R., Guarani, V., Vaites,
L. P., Ordureau, A., Rad, R., et al. (2015) The BioPlex Network: a system-
atic exploration of the human interactome. Cell 162, 425–440 CrossRef
Medline
25. Reed, B. J., Locke, M. N., and Gardner, R. G. (2015) A conserved deubiq-
uitinating enzyme uses intrinsically disordered regions to scaffold multi-
ple protein interaction sites. J. Biol. Chem. 290, 20601–20612 CrossRef
Medline
26. Liu, J., Xu, Y., Stoleru, D., and Salic, A. (2012) Imaging protein synthesis in
cells and tissues with an alkyne analog of puromycin. Proc. Natl. Acad. Sci.
U.S.A. 109, 413–418 CrossRef Medline
27. Cowley, G. S., Weir, B. A., Vazquez, F., Tamayo, P., Scott, J. A., Rusin, S.,
East-Seletsky, A., Ali, L. D., Gerath,W. F., Pantel, S. E., Lizotte, P. H., Jiang,
G., Hsiao, J., Tsherniak, A., Dwinell, E., et al. (2014) Parallel genome-scale
loss of function screens in 216 cancer cell lines for the identification of
context-specific genetic dependencies. Sci. Data 1, 140035 CrossRef
28. Wang, T., Birsoy, K., Hughes, N. W., Krupczak, K. M., Post, Y., Wei, J. J.,
Lander, E. S., and Sabatini, D. M. (2015) Identification and characteriza-
tion of essential genes in the human genome. Science 350, 1096–1101
CrossRef Medline
29. Blomen, V. A., Máájek, P., Jae, L. T., Bigenzahn, J. W., Nieuwenhuis, J.,
Staring, J., Sacco, R., van Diemen, F. R., Olk, N., Stukalov, A., Marceau, C.,
Janssen, H., Carette, J. E., Bennett, K. L., Colinge, J., Superti-Furga, G., and
Brummelkamp, T. R. (2015) Gene essentiality and synthetic lethality in
haploid human cells. Science 350, 1092–1096 CrossRef Medline
30. Lerch-Gaggl, A., Haque, J., Li, J., Ning, G., Traktman, P., andDuncan, S. A.
(2002) Pescadillo is essential for nucleolar assembly, ribosome biogenesis,
and mammalian cell proliferation. J. Biol. Chem. 277, 45347–45355
CrossRef Medline
31. Chen, H., Li, Z., Haruna, K., Li, Z., Li, Z., Semba, K., Araki, M., Yamamura,
K., and Araki, K. (2008) Early pre-implantation lethality in mice carrying
truncated mutation in the RNA polymerase 1–2 gene. Biochem. Biophys.
Res. Commun. 365, 636–642 CrossRef Medline
32. Newton, K., Petfalski, E., Tollervey, D., and Cáceres, J. F. (2003) Fibrillarin
is essential for early development and required for accumulation of an
intron-encoded small nucleolar RNA in the mouse. Mol. Cell Biol. 23,
8519–8527 CrossRef Medline
33. Romanova, L. G., Anger, M., Zatsepina, O. V., and Schultz, R. M. (2006)
Implication of nucleolar protein SURF6 in ribosome biogenesis and pre-
implantation mouse development. Biol. Reprod. 75, 690–696 CrossRef
Medline
34. Hamdane, N., Stefanovsky, V. Y., Tremblay,M.G., Németh, A., Paquet, E.,
Lessard, F., Sanij, E., Hannan, R., and Moss, T. (2014) Conditional inacti-
vation of upstream binding factor reveals its epigenetic functions and the
existence of a somatic nucleolar precursor body. PLoS Genet. 10,
e1004505 CrossRef Medline
35. Zhu,Q., Yasumoto, H., andTsai, R. Y. (2006)Nucleostemin delays cellular
senescence and negatively regulates TRF1 protein stability.Mol. Cell Biol.
26, 9279–9290 CrossRef Medline
36. Nicolas, E., Parisot, P., Pinto-Monteiro, C., de Walque, R., De Vleeschou-
wer, C., and Lafontaine, D. L. (2016) Involvement of human ribosomal
proteins in nucleolar structure and p53-dependent nucleolar stress. Nat.
Commun. 7, 11390 CrossRef Medline
37. Brighenti, E., Treré, D., and Derenzini, M. (2015) Targeted cancer therapy
with ribosome biogenesis inhibitors: a real possibility? Oncotarget 6,
38617–38627 CrossRef Medline
38. Quirós, P. M., Ramsay, A. J., Sala, D., Fernández-Vizarra, E., Rodríguez, F.,
Peinado, J. R., Fernández-García, M. S., Vega, J. A., Enríquez, J. A., Zor-
zano, A., and López-Otín, C. (2012) Loss of mitochondrial protease
OMA1 alters processing of the GTPase OPA1 and causes obesity and
defective thermogenesis in mice. EMBO J. 31, 2117–2133 CrossRef
Medline
39. Fraile, J. M., Ordonez, G. R., Quiros, P. M., Astudillo, A., Galvan, J. A.,
Colomer, D., Lopez-Otin, C., Freije, J. M., and Puente, X. S. (2013) Iden-
tification of novel tumor suppressor proteases by degradome profiling of
colorectal carcinomas. Oncotarget 4, 1919–1932 CrossRef
40. Paulo, J. A., O’Connell, J. D., Gaun, A., and Gygi, S. P. (2015) Proteome-
wide quantitative multiplexed profiling of protein expression: carbon-
source dependency in Saccharomyces cerevisiae. Mol. Biol. Cell 26,
4063–4074 CrossRef Medline
41. McAlister, G. C., Nusinow, D. P., Jedrychowski, M. P., Wühr, M., Huttlin,
E. L., Erickson, B. K., Rad, R., Haas, W., and Gygi, S. P. (2014) MultiNotch
MS3 enables accurate, sensitive, and multiplexed detection of differential
expression across cancer cell line proteomes.Anal. Chem. 86, 7150–7158
CrossRef Medline
42. Huttlin, E. L., Jedrychowski, M. P., Elias, J. E., Goswami, T., Rad, R., Beau-
soleil, S. A., Villén, J., Haas, W., Sowa, M. E., and Gygi, S. P. (2010) A
tissue-specific atlas of mouse protein phosphorylation and expression.
Cell 143, 1174–1189 CrossRef Medline
43. Osorio, F. G., Soria-Valles, C., Santiago-Fernández, O., Bernal, T., Mittel-
brunn, M., Colado, E., Rodríguez, F., Bonzon-Kulichenko, E., Vázquez, J.,
Porta-de la-Riva, -M., Cerón, J., Fueyo, A., Li, J., Green, A. R., Freije, J. M.,
and López-Otín, C. (2016) Loss of the proteostasis factor AIRAPL causes
myeloid transformation by deregulating IGF-1 signaling. Nat. Med. 22,
91–96 Medline
44. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L.,
Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S.,
andMesirov, J. P. (2005)Gene set enrichment analysis: a knowledge-based
approach for interpreting genome-wide expression profiles. Proc. Natl.
Acad. Sci. U.S.A. 102, 15545–15550 CrossRef Medline
USP36 loss destabilizes DHX33 and causes embryonic lethality
2194 J. Biol. Chem. (2018) 293(6) 2183–2194
 at U
N
IV
ERSID
A
D
 D
E O
V
IED
O
 on D
ecem
ber 10, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
José I. Martín-Subero, José M. P. Freije and Carlos López-Otín
Vilarrasa-Blasi, Nuria Verdaguer-Dot, Miguel A. Prado, Joao A. Paulo, Steven P. Gygi, 
Julia M. Fraile, Diana Campos-Iglesias, Francisco Rodríguez, Aurora Astudillo, Roser
preimplantation lethality in mice
Loss of the deubiquitinase USP36 destabilizes the RNA helicase DHX33 and causes
doi: 10.1074/jbc.M117.788430 originally published online December 22, 2017
2018, 293:2183-2194.J. Biol. Chem. 
  
 10.1074/jbc.M117.788430Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/293/6/2183.full.html#ref-list-1
This article cites 44 references, 17 of which can be accessed free at
 at U
N
IV
ERSID
A
D
 D
E O
V
IED
O
 on D
ecem
ber 10, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
